Lipid oligonucleotide conjugates as responsive nanomaterials for drug delivery
Related Experiment Video
Updated: Oct 21, 2026

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications
Published on: November 17, 2015
Oleksandr Pokholenko1, Arnaud Gissot, Brune Vialet
1Université Bordeaux Segalen, 146 rue Léo Saignat, 33076 Bordeaux Cedex, France. philippe.barthelemy@inserm.fr.
Abstract:
We report Lipid OligoNucleotide conjugates (LONs) bearing either two or three hydrophobic chains. LONs self-assemble into micellar aggregates, which provide a suitable reservoir for hydrophobic drugs such as paclitaxel. Our results demonstrate that the composition of the LONs both in terms of the lipid and the oligonucleotide sequence impacts their ability to host lipophilic molecules. Interestingly, binding of the complementary oligonucleotide selectively induces the release of part of the drug payload of the aggregates. These LON based micelles, which efficiently host hydrophobic drugs, represent an original stimuli-responsive drug delivery system.
More Related Videos
Related Concept Videos
Modified-Release Drug Delivery Systems: Site-Targeted
Site-Targeted Drug Delivery Systems: Polymeric Carriers

